Kirk Tanner

Kirk Tanner

Company: National Brain Tumor Society

Job title: Chief Scientific Officer


Panel: It’s All in the Money – Funding Challenges & Opportunities in the GBM Space 10:40 am

Explore the challenges of funding development How can drug developers inspire and attract companies to invest in their novel preclinical glioblastoma development and pipeline? How can the industry come together to overcome the paucity of funding?Read more

day: Day Two

Panel: Why Are We Not Doing Better? An Open Discussion of the Limitations of Current Drug Development for GBM and Where the Field Can Improve 9:25 am

Barriers to advancing drug development and strategies to address these Major therapeutic strategies currently under development How can drug developers cut to the real barriers, and debate what is truly required to break through to successful treatments for GBM?Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.